Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Accounts like @longevity_hackers typically run through a peptide stack, often BPC-157, TB-500, CJC-1295, ipamorelin, or GHK-Cu, and frame each one as a performance or longevity upgrade with near-miraculous tissue repair and anti-aging effects. The pitch usually involves some version of: these peptides do what your body already does, just amplified. Expect claims about accelerated recovery, improved sleep quality, increased growth hormone output, and skin or collagen regeneration. MK-677 often gets lumped in here despite being a small molecule, not a peptide, because it mimics ghrelin and raises IGF-1. Semax and selank may get mentioned as nootropic add-ons. The framing tends to be "biohacker discovers what doctors won't tell you," which is both a marketing structure and a red flag. None of these compounds are FDA-approved for the uses being described, and that fact rarely makes it into the TikTok.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and the evidence quality varies wildly. BPC-157 has genuine animal data, Seiwerth et al. (2014, Current Pharmaceutical Design) showed accelerated tendon-to-bone healing in rat models at doses around 10 mcg/kg. The problem is there are zero completed human RCTs. TB-500 (thymosin beta-4) similarly has promising preclinical data for cardiac and wound repair, but human trials are sparse and mostly in specific injury populations. CJC-1295 with DAC does raise IGF-1 levels in humans, Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism) confirmed this across a 28-day window at doses of 1-2 mg weekly, but "raises IGF-1" is not the same as "reverses aging." GHK-Cu has legitimate copper-binding and collagen-synthesis data in vitro (Pickart et al., 2015, Journal of Aging Research), but controlled human trials are thin. MK-677 is the most-studied of this group and still only shows modest lean mass effects with real side effects including insulin resistance and edema.

Where does the social media noise diverge from clinical reality?

The divergence is significant and specific. First, most peptide advocates present animal studies as if they directly translate to human outcomes. They don't. Rat tendon healing at 10 mcg/kg tells you almost nothing about whether subcutaneous BPC-157 does anything useful in a 200-pound adult. Second, "growth hormone pulse" language around CJC-1295 and ipamorelin stacks gets thrown around without acknowledging that artificially elevating GH secretion carries real risks, including potential IGF-1-driven proliferative effects in people with undiagnosed conditions. Third, the stability and sterility of compounded peptides sold online is a serious and underreported issue. A 2022 FDA review flagged multiple compounded peptide products for contamination and incorrect concentration. Fourth, semax and selank have Russian-origin clinical literature that is difficult to independently verify and has not been replicated in Western peer-reviewed journals. Presenting them as established nootropics is a significant overreach.

What should you actually know?

Peptides are a legitimate area of pharmaceutical research. Some, like tesamorelin and bremelanotide, have gone through full FDA approval processes and earned specific indications. The ones circulating in longevity TikTok have not. That doesn't mean they're useless, but it means the risk-benefit math is genuinely unknown for most people. The delivery method matters too: peptides are typically degraded in the gut, which is why injectable forms are used in research, and the unregulated injectable peptide market carries infection risk that no TikTok biohacker addresses honestly. If you're curious about peptide therapy, a telehealth provider who can review your labs, your health history, and your actual goals is the starting point, not a 60-second video optimized for shares. The longevity space is full of people selling certainty that the data simply doesn't support.